Executive Director, Global Market Development (Friedreich’s Ataxia) – Solid Biosciences
Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy (Duchenne), Friedreich’s ataxia (FA), catecholaminergic polymorphic ventricular tachycardia (CPVT), TNNT2-mediated dilated cardiomyopathy, BAG3-mediated dilated cardiomyopathy, and additional fatal, genetic cardiac diseases. We are advancing a diverse pipeline and delivery platform in the pursuit of uniting experts in science, technology, disease management, and care.
Patient-focused and founded by those directly impacted by Duchenne, Solid’s mission is to improve the daily lives of patients living with devastating rare diseases.
We are seeking a strategic and externally focused Executive Director, Global Market Development (Friedreich’s Ataxia) to lead the development and execution of Solid’s global key opinion leader (KOL) strategy for the FA program. This individual will play a critical role in shaping global external engagement, deepening scientific and clinical partnerships, and accelerating awareness and preparedness for Solid’s gene therapy programs. The role has a strong international focus, particularly across Europe, with exploratory engagement in the Middle East, and will require extensive global travel.
This role will report to the Chief Operating Officer and is a remote position (U.S. or Europe-based candidates strongly considered), with significant international travel required.
Key Position Responsibilities
Experience Requirements
Key Position Attributes
Compensation
The base compensation range for this role is: $254,000 - $298,500
Base salary offered is determined through an internal analysis utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Regular employees are eligible to receive both short-term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward individual performance and align incentives to Solid’s long term company performance.
Benefits and Solid Advantages
At Solid Biosciences we offer a highly competitive total rewards and benefits package, intended to support all aspects of our employees’ lives and well-being. Additionally, for those employees working onsite at our Hood Park Headquarters, we offer a variety of onsite resources to support those working in our offices.

BP

US Tech Solutions

MEDIFOX DAN

N26

Solid Biosciences

Solid Biosciences